Keywords
cognitive impairment
intensive care
quercetin
2-ethyl-6-methyl-3-hydroxypyrimidine succinate
3-methyl-1,2,4-triazolin-5 morpholinium thiocetam
How to Cite
Abstract
The study included 105 patients aged up to 60 years. The patients were divided into three age groups: 34–40 years, 41–50, 51–60 years respectively. In order to assess the state of cognitive impairment, use such neuropsychological tests as MMSE, the clock drawing test, and the «memorization of 10 words» test by A. R. Luria. Each group of patients was divided into 3 subgroups and entered, respectively, 3 treatment regimens. The first treatment regimen included quercetin, the second is quercetin + 2 ethyl-6-methyl-3-hydroxypyrimidine succinate, the third is quercetin + morpholini 3-methyl-1,2,4-triazolin-5 thiocetam. In patients of different age groups, with the help of neuropsychological tests with a high degree of reliability it can be argued that the use of morpholine 3-methyl-1,2,4-triazolin-5 tiocetam, led to improvement of cognitive functions according to the indicators of patients , receiving treatment according to Schemes 1 and 2. For the purpose of the rapid and effective recovery of cognitive functions in patients of working agewith acute myocardial infarction, from the first hour of hospitalization, the following regimen of treatment should be prescribed: quercetin and my foliniyu 3-methyl-1,2,4-tryazolin 5 tiotsetam for 10 days. This allows already at the 10th day to restore the initial level of cognitive function and in the future to significantly increase them.References
Bilchenko A.V., Matyuha L.V. (2014). Kognitivnyie narusheniia i dementsiia u patsientov s arterialnoi hipertenziei [Cognitive impairment and dementia in patients with arterial hypertension]. Ukrainskii meditsinskii chasopys – Ukrainian Medical Journal, № 6 (104), pp. 71–76 [in Russian].
Bagorova N.V. (2017). Holesterin i eho vliianie na orhanizm [Cholesterol and its effect on the body]. Innovatsionnaia nauka – Innovative science, № 2, pp. 209–211 [in Russian].
Gandzyuk V.A. (2014). Analiz zahvoriuvanosti na ishemichnu hvorobu sertsia v Ukraini [The role of cardiovascular pathology in the formation and progression of cognitive impairment]. Ukrainskyi kardiolohichnyi zhurnal – Ukrainian Cardiology Magazine, № 3, pp. 45–52 [in Ukrainian].
Aleksandrova N.A., Evzelman M.A., Fominova M.V. (2009). Sosudistyie kohnitivnyie rasstroistva u bolnyih v ostroi faze insulta [Vascular cognitive disorders in patients with acute phase of stroke]. Uchenyie zapiski Orlovskoho hosudarstvennoho universiteta – Scientific notes of the Orlov State University, № 2, pp. 129–131 [in Russian].
Boholepova A.N., Semushkina E.G. (2011). Rol serdechno-sosudistoi patolohii v formirovanii i prohressirovanii kohnitivnyh narusheniu [The role of cardiovascular pathology in the formation and progression of cognitive impairment]. Nevrolohicheskii zhurnal – Neurological Journal, vol. 16, № 4, pp. 27–31 [in Russian].
Okovityi S.V., Suhanov D.S., Zaplutanov V.A., Smahina A.N. (2012). Antihipoksanty v sovremennoi klinicheskoi praktike [Antihypoxants in modern clinical practice]. Klinicheskaia meditsina – Clinical medicine, № 9, pp. 63–68 [in Russian].
Borovkov N.N., Golitsyina N.A. (2018). Znachenie opredeleniia vyisokochuvstvitelnoho troponina v rannei diahnostike ostroho infarkta miokarda [The value of the definition of highly sensitive troponin in the early diagnosis of acute myocardial infarction]. Klinicheskaia meditsina – Clinical medicine, vol. 96, № 1, pp. 25–29 [in Russian].
Goloschapov-Aksenov R.S., Aksenov V.V., Lutsenko V.D. (2018). Prohnozirovanie ostroho infarkta miokarda po biohimicheskim kardiomarkeram krovi [Forecasting of acute myocardial infarction by biochemical cardiomarkers of blood]. Klinicheskaia laboratornaia diahnostika – Clinical laboratory diagnostics, vol. 63, № 2, pp. 85–89 [in Russian].